N/A
Manufactured by The Mentholatum Company
2 FDA adverse event reports analyzed
Last updated: 2026-04-15
DIMETHICONE, OCTINOXATE, OCTISALATE, OXYBENZONE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by The Mentholatum Company. The most commonly reported adverse reactions for DIMETHICONE, OCTINOXATE, OCTISALATE, OXYBENZONE include BLISTER, ORAL DISCOMFORT. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DIMETHICONE, OCTINOXATE, OCTISALATE, OXYBENZONE.
Out of 1 classified reports for DIMETHICONE, OCTINOXATE, OCTISALATE, OXYBENZONE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 2 FDA FAERS reports that mention DIMETHICONE, OCTINOXATE, OCTISALATE, OXYBENZONE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include BLISTER, ORAL DISCOMFORT. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list The Mentholatum Company in connection with DIMETHICONE, OCTINOXATE, OCTISALATE, OXYBENZONE. Always verify the specific product and NDC with your pharmacist.